Edition:
United Kingdom

Natus Medical Inc (BABY.OQ)

BABY.OQ on NASDAQ Stock Exchange Global Select Market

35.35USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$35.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,948
52-wk High
$43.55
52-wk Low
$28.05

Chart for

About

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and... (more)

Overall

Beta: 0.49
Market Cap(Mil.): $1,178.92
Shares Outstanding(Mil.): 33.30
Dividend: --
Yield (%): --

Financials

  BABY.OQ Industry Sector
P/E (TTM): -- 34.90 32.59
EPS (TTM): -0.10 -- --
ROI: -0.55 8.09 12.60
ROE: -0.79 11.51 14.49

BRIEF-Voce Catalyst Urges Natus Medical Shareholders To Vote For Election Of Its Nominees, Removal Of Co's Chairman

* VOCE CATALYST PARTNERS LP URGES NATUS MEDICAL INC SHAREHOLDERS TO VOTE FOR ELECTION OF ITS NOMINEES AND FOR REMOVAL OF CO'S CHAIRMAN

07 May 2018

BRIEF-Natus Medical Reports Q1 Non-GAAP Earnings Per Share Of $0.24

* Q1 EARNINGS PER SHARE VIEW $0.24 -- THOMSON REUTERS I/B/E/S

25 Apr 2018

BRIEF-Natus Medical Inc Confirms Receipt Of Notice From Voce Capital

* NATUS CONFIRMS RECEIPT OF NOTICE OF VOCE CAPITAL’S INTENT TO NOMINATE DIRECTOR CANDIDATES TO REPLACE 50% OF THE NATUS BOARD

23 Apr 2018

BRIEF-Natus Announces $30 Million Share Repurchase Program

* NATUS MEDICAL - TO USE CASH ON HAND, CASH GENERATED FROM OPERATIONS, EXISTING CREDIT FACILITIES OR OTHER FINANCING TO FUND SHARE REPURCHASE PROGRAM Source text for Eikon: Further company coverage:

22 Feb 2018

BRIEF-Natus Medical Announces 2018 Annual And First Quarter Financial Guidance

* REVENUE IN Q4 WAS LOWER THAN EXPECTED DUE TO WEAKNESS IN OUR U.S. NEURODIAGNOSTIC BUSINESS

08 Jan 2018

Earnings vs. Estimates